Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3983 |  HYPR Hyperfine, Inc. - Class A Common Stock | 0.98 USD | -3.92% | -12.50% | -31.94% | -5.77% | 97.28 M USD | ||
| 3985 |  RPID Rapid Micro Biosystems, Inc. - Class A Common Stock | 2.09 USD | -5.43% | +20.81% | +22.94% | -39.24% | 96.49 M USD | ||
| 3990 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.56 USD | -1.77% | -15.37% | -4.96% | -7.64% | 95.51 M USD | ||
| 3994 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.19 USD | -0.38% | -4.24% | +13.82% | +36.58% | 94.48 M USD | ||
| 3998 |  PTHS Pelthos Therapeutics Inc. Common Stock | 26.93 USD | -3.75% | +0.67% | -1.79% | +33.85% | 93.60 M USD | ||
| 4005 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.12 USD | -4.27% | -5.88% | +0.90% | -17.65% | 92.15 M USD | ||
| 4010 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.26 USD | -2.33% | -3.08% | +2.44% | -32.98% | 91.10 M USD | ||
| 4012 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.57 USD | -7.65% | -25.94% | -37.20% | -36.69% | 90.91 M USD | ||
| 4014 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.48 USD | +9.09% | +11.63% | +20.00% | -76.35% | 90.85 M USD | ||
| 4019 |  BTMD Biote Corp. - Class A common stock | 2.38 USD | +9.68% | +3.93% | +3.93% | -43.33% | 89.44 M USD | ||
| 4026 |  PARK Park Dental Partners, Inc. - Common Stock | 19.52 USD | -0.46% | -4.50% | +9.97% | +50.15% | 88.13 M USD | ||
| 4033 |  DH Definitive Healthcare Corp. - Class A Common Stock | 0.82 USD | +1.23% | +2.50% | +2.50% | -79.85% | 86.53 M USD | ||
| 4036 |  SERA Sera Prognostics, Inc. - Class A Common Stock | 2.20 USD | +1.85% | +7.84% | +17.02% | -14.73% | 86.15 M USD | ||
| 4044 |  RLYB Rallybio Corporation - Common Stock | 15.96 USD | -1.05% | +1.33% | +0.25% | +3446.67% | 84.56 M USD | ||
| 4045 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 3.25 USD | -8.19% | -27.62% | -33.40% | -62.94% | 84.54 M USD | ||
| 4049 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.94 USD | -1.05% | -13.76% | -37.33% | +36.23% | 84.13 M USD | ||
| 4051 |  NRXS Neuraxis, Inc. Common Stock | 6.77 USD | -2.59% | -7.26% | -4.92% | +24.68% | 83.84 M USD | ||
| 4056 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.67 USD | -1.47% | -5.63% | -12.99% | +63.41% | 83.00 M USD | ||
| 4066 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.19 USD | -1.65% | -6.30% | -7.75% | -60.98% | 81.84 M USD | ||
| 4069 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.34 USD | -8.22% | -8.22% | 0.00% | -35.58% | 81.47 M USD |
Notizie Titoli del Settore Sanitario
Relazione sugli utili: DBV Technologies in calo dopo l’aggiornamento sul Q2 2026
Takeda presenta i risultati dello studio su zasocitinib per la psoriasi
Relazione sugli utili: Intuitive Surgical supera le stime del Q2 2026, il titolo cede
Canaccord conferma il rating su STAAR Surgical dopo i ricavi del Q2
Jasper Therapeutics acquisisce Kira Pharmaceuticals per 132 milioni
Perché il titolo Regenxbio crolla oggi?
AptarGroup dichiara un dividendo trimestrale di $0,48
Gainers Titoli del Settore Sanitario
 GNPX Genprex, Inc. - Common Stock | 8.00 | +1532.65% |
 SRZNW Surrozen, Inc. - Warrant | 0.0156 | +136.36% |
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0837 | +67.40% |
 LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.15 | +36.36% |
 CDNA CareDx, Inc. - Common Stock | 40.34 | +35.60% |
 ATAI AtaiBeckley Inc. - Common Stock | 7.15 | +33.40% |
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.0999 | +23.33% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 23.27 | +21.26% |
Losers Titoli del Settore Sanitario
 WGSWW GeneDx Holdings Corp. - Warrant | 0.0006 | -71.43% |
 DRMAW Dermata Therapeutics, Inc. - Warrant | 0.0080 | -32.20% |
 JAGX Jaguar Health, Inc. - Common Stock | 1.34 | -30.93% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.61 | -28.24% |
 MODD Modular Medical, Inc. - common stock | 3.24 | -22.67% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.46 | -20.69% |
 ENLV Enlivex Ltd. - Ordinary Shares | 4.75 | -18.66% |
 NXGLW NexGel, Inc - Warrant | 0.0262 | -17.87% |